Dr. Jayanthi Koneru presented the DEEP abstract results today at #HRS2025, showcasing the long-term effectiveness and durability of Hybrid Ablation in treating Advanced Afib patients.
The AtriClip® device portfolio provides versatile options for both MIS and open procedures for LAAE. Whether you need a standard or low-profile solution, we have options designed for complete closure.
Stop by Booth 915 at #HRS2025 to explore our full range!
Important Safety
Dr. DJ Lakkireddy shared valuable insights at #HRS2025 about a national survey conducted among 146 non-cardiologists and general cardiologists across the U.S. The purpose was to determine their familiarity with symptomatic inappropriate sinus tachycardia (IST) and available
We're passionately focused on the continued innovation and science behind our AtriClip® device portfolio. With over 600,000 devices implanted and more than 90 studies, we’re setting the gold standard to surgical LAAE.
Stop by booth 915 at #HRS2025 to see the latest
Inappropriate Sinus Tachycardia (IST) is a potentially debilitating heart condition that more often affects younger women.
Drugs like beta blockers and ivabradine have limited effectiveness in controlling high heart rate in some patients.
A new hybrid ablation procedure is currently being studied in the HEAL-IST Trial to treat patients with symptomatic IST who are intolerant or refractory to medications.
Learn more about who might qualify by visiting HEAL-IST.com.
#ClinicalTrial#Cardiac
On World Health Day, we're inspired by the incredible journey of Bob Gates. After three unsuccessful ablations, Bob and his wife took matters into their own hands, advocating for the right treatment.
Now, 6 years later, Bob is Afib-free and living life to the fullest. Check out his amazing story here: https://okt.to/u1mwkX
#WorldHealthDay#Afib#HybridAFTherapy
AtriCure is proud to support the American Heart Association and its mission to create healthier lives. This year's Cincinnati Heart Mini and the Minneapolis CycleNation were two incredible events — full of energy, smiles, and a shared commitment to advancing heart health.
#AHA
Congratulations to Sarah, Vanessa and Kristen on their spotlights in the Cincinnati Business Courier - People on the Move Women’s History Month feature! This recognition highlights the impact they make in business and in their communities. Join us in congratulating them and check out their profiles below:
Sarah Payne: https://okt.to/mGkuUc
Vanessa Parker: https://okt.to/C6zycu
Kristen Mees: https://okt.to/lV5bic
Attention medical device sales professionals – we’re hiring! Join a rapidly growing organization committed to advancing patient care. Our sales team works alongside physicians in the operating room or labs, providing expert guidance to enhance product utilization and patient outcomes.
If you're ready to make a difference, check out our open positions and apply today!
https://okt.to/Vla4W0
#Hiring
Dr. Jayanthi Koneru presented the DEEP abstract results today at #HRS2025, showcasing the long-term effectiveness and durability of Hybrid Ablation in treating Advanced Afib patients.
The DEEP Trial revealed that 71.6% of patients with Advanced Afib disease* had no recurring atrial arrhythmias** one year after the procedure, and 62.4% remained arrhythmia-free two years post-procedure.
*Persistent or long-standing persistent Afib
**Afib, atrial flutter, atrial tachycardia episodes >30 sec, off anti-arrhythmic drugs (AAD, if reported) and regardless of AAD status.
The AtriClip® device portfolio provides versatile options for both MIS and open procedures for left atrial appendage exclusion (LAAE). Whether you need a standard or low-profile solution, we have options designed for complete closure.
Stop by Booth 915 at #HRS2025 to explore our full range!
Important Safety Information: https://okt.to/83Lskg
Dr. Dhanunjaya (DJ) Lakkireddy MD, MBA shared valuable insights at #HRS2025 about a national survey conducted among 146 non-cardiologists and general cardiologists across the U.S. The purpose was to determine their familiarity with symptomatic inappropriate sinus tachycardia (IST) and available treatment options. Although awareness of IST was low, more than half of cardiologists and general practitioners said they encounter IST patients regularly.
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Patients and Caregivers. If you are a Healthcare Professional, please visit the 'Healthcare Professionals' page.
Click "Agree" to confirm you are a Patient or a Caregiver.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
social media channels to keep updated on the latest at AtriCure.
AtriClip FLEX∙V™ Device Animation
Duration: 2:9
AtriClip PRO2® Animation in a Mini AVR Procedure with LAA Occlusion
Duration: 3:47
Mechanism of Action Comparison AOD vs AOD2 AtriClip Devices
Duration: 1:25
AtriCure: Impacting Lives, One Patient at a Time
Duration: 6:9